Clinical Trial

Mediating Role of Myokines in the Dialogue Between Muscle and Bone Tissue in a Population of Healthy Women Aged 20-89 Years

Study acronym: MyOs
Recruiting
View on ClinicalTrials.gov →
Summary
The main hypothesis is that muscle acts on bone tissue via the secretion of myokines (myostatin, follistatin, irisin). This is based on previous results showing that muscle mass in different patient populations with very different body mass indexes (anorexic or obese patients) is significantly and independently associated with bone mineral density.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-11-08; most recent amendment 2024-11-27.
Status change: Not Yet Recruiting → Recruiting 2024-11-27
Trial Details
NCT Number NCT06683222
Lead Sponsor Centre Hospitalier Universitaire de Nīmes
Conditions Bone Density
Enrollment 280 participants
Start Date 2024-11-06
Primary Completion 2029-09-01 (estimated)
Study Completion 2029-09-30 (estimated)
Updated on ClinicalTrials.gov 2024-11-29